USPTO Grants Patent for Multifocal Intraocular Lens

The United States Patent and Trademark Office (USPTO) has issued patent US12582516B2 for a multifocal intraocular lens (IOL) to HANITA LENSES LTD. The patent, effective March 24, 2026, details an IOL design incorporating a diffractive surface with specific topographical characteristics and an asymmetrical energy flux distribution across its diffractive orders. The filing date for this patent was September 12, 2019, under application number 17276198, and it includes 13 claims.

This patent grant represents a new intellectual property asset for HANITA LENSES LTD. For medical device manufacturers and pharmaceutical companies involved in ophthalmic products, this signifies a new patented technology in the field of multifocal IOLs. While this is a patent grant and not a regulatory rule, it impacts the competitive landscape and may require companies to review their own product development and intellectual property strategies to ensure freedom to operate or to identify potential licensing opportunities. No immediate compliance actions are required for entities not directly involved in the development or manufacturing of this specific technology.